Skip to main content

Interchangeability of B type natriuretic peptide measurements in lithium heparin and K2EDTA: agreement between matrices and differences in diagnostic accuracy.

Stenner E, Buiatti A, Bussani A, Merlo M, d'Amario C, Barbati G, Sinagra G, Biasioli B

Publication: Clin Chim Acta (2011) • Vol 412 • Page 215-6PMID: 20875403View on PubMed

Purpose

The purpose of this paper was to determine the effects of anticoagulant on B type natriuretic peptide (BNP) measurements in plasma.

Conclusion

Results suggest that lithiuim heparin can be used as an alternative to the recommended EDTA for BNP assays. Data was examined from 52 patients with BNP tests using blood drawn into each anticoagulant and an additional 239 patients with BNP tests performed only with EDTA-plasma and a computer simulation of Heparin-plasma BNP results.

Studies (1)

Purpose

The purpose of this study was to determine the effects of anticoagulant on BNP measurements in plasma.

Summary of Findings

A linear relationship was noted between BNP tests using EDTA and lithium heparin. At a threshold of 100 ng/L, the sensitivity and specificity were 1 and 0.558 for EDTA-plasma and 0.92 and 0.63 for heparin-plasma, respectively. Results suggest that lithiuim heparin can be used as an alternative to the recommended EDTA for BNP assays. The authors note the small sample size of specimens collected with both anticoagulants (52) as opposed to those collected with EDTA and compared to computer simulated heparin (239) is a weakness of this study.

  • Biospecimens

    FluidPlasma
    FluidBlood
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Cardiovascular Disease
    Other diagnoses
  • Platforms

    PeptideClinical chemistry/auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Symptoms of heart failure
    Biospecimen AcquisitionAnticoagulant
    Lithium heparin
    Potassium EDTA